| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 18, 2005
Accepted on August 15, 2005
in the Presence of Fibrinogen Requires
V
3
From Hematology/Oncology Unit, Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, NY.
* To whom correspondence should be addressed. E-mail: Abha_Sahni{at}urmc.rochester.edu.
Objective--The purpose of this study was to investigate the receptor requirements for enhanced IL-1
-induced secretion of nitric oxide (NO) by endothelial cells (ECs) in the presence of fibrinogen.
Methods and Results--ECs were exposed to IL-1
with or without fibrinogen and NO was measured as nitrite. NO production by EC exposed to fibrinogen (0.3±0.1 µmol/L) was comparable concentration to control (0.2±0.1 µmol/L), but IL-1
significantly increased NO production (0.8±0.1 µmol/L), and the combination of both fibrinogen and IL-1
resulted in a further increase to 2.2±0.2 µmol/L (P<0.002). 7E3 or LM609, antibodies to
v
3, inhibited NO production stimulated by fibrinogen-bound IL-1
to 0.2±0.1 µmol/L (P<0.001) or 0.2±0.03 µmol/L (P<0.0001), respectively. These levels were comparable to control and significantly less than with IL-1
(P<0.002). EC or fibroblasts exposed to both fibrinogen and IL-1
, but not vitronectin and IL-1
, demonstrated positive Western blotting for
V
3 after immunopurification with anti- IL-1R, indicating specific association between
v
3 and IL-1R. Dual immunofluorescence also revealed colocalization of
v
3 and IL-1R only when the cells were exposed to both fibrinogen and IL-1
.
Conclusion--The enhanced NO production by ECs in the presence of fibrinogen-bound IL-1
requires the coordinated effects of colocalized
V
3 and IL-1R.
nitric oxide
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |